CYRAMZA conc perf 500 mg/50ml flac
7680652060022
CH-65206
L01FG02
07.16.1.
Reimbursement limitations:
CYRAMZA.01
En association avec le paclitaxel pour le traitement des patients adultes ayant un ECOG PS …
1 / 3
google
Details
- Product number
- 6520602
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ramucirumabum 500 mg, histidinum, histidini hydrochloridum monohydricum, glycinum, natrii chloridum corresp. natrium 86.2 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 50 ml.
Articles (1)
Cyramza 500mg/50ml, concentré pour solution de perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
86.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2041.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2016
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 65206
- Drug name
- Cyramza, concentré pour solution de perfusion
- Galenic form
- KOPA
- ATC Code
- L01FG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/10/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CYRAMZA conc perf 500 mg/50ml flac
- Description (DE)
- CYRAMZA Inf Konz 500 mg/50ml Durchstf
- Market launch
- 29/10/2015
- Narcotic (BTM)
- No